Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq Global Market. The firm announced on Monday the launch of its initial public offering of 11.0 million common shares.

The biotech firm is targeting the share price between US$15.00 and US$17.00 per share, which puts target proceeds from the offering at US$187 million on the high end of the range.

The shares are expected to trade on the Nasdaq big board under the symbol “CINC”. The underwriters also have a 30-day over-allotment option to purchase additional 1.65 million shares.

The pharmaceutical firm is focused on its lead drug candidate CIN-107, an oral aldosterone synthase inhibitor which makes it a potential treatment for hypertension and other cardio-renal diseases. The drug is currently in two phase 2 clinical trials, one for treatment-resistant hypertension and one for primary aldosteronism.

The company is led by CEO Marc de Garidel, a former CEO and the current board chairman of Euronext Paris-listed pharmaceutical firm Ipsen.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

200 Grams of Gold And 21% Copper — That’s Not Normal | Matt Wilson – Sterling Metals

Silver at $100? This Time It Might Stay There. | David Morgan

Critical Minerals Are Rerating! | John Passalacqua – First Phosphate

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Asset Manager TPG Prices US$1 Billion IPO

Private equity firm TPG Inc. (Nasdaq: TPG) began trading on the Nasdaq Global Select Market...

Thursday, January 13, 2022, 02:22:00 PM

Online Car Retailer Vroom Files for IPO

Rumours have started swirling that online used-car seller Vroom has filed for an initial public...

Monday, May 11, 2020, 06:17:23 PM

Edtech Firm Genius Group Prices US$19.6 Million IPO

Edtech and education group Genius Group Limited (NYSE: GNS) began trading on the New York...

Tuesday, April 12, 2022, 02:19:00 PM

Consumer Goods SPAC Conyers Park III Acquisition Seeks To Raise US$350 Million In IPO

Special purpose acquisition company Conyers Park III Acquisition Corp. (Nasdaq: CPAAU) went public on Nasdaq...

Tuesday, August 10, 2021, 02:12:00 PM

Freight Payment Platform Freightos To Be Taken Public In A US$435 Million SPAC Merger

Freight booking and payment platform Freightos Limited is looking to debut on the Nasdaq after...

Wednesday, June 1, 2022, 02:21:00 PM